Profil
Mr. Daniel Biedermann is a Portfolio Manager at 2trade Group Ltd.
He began his career in portfolio management at Swiss Bank Corp.
before joining Roche in 1988, where he also served as Head of the Investment Committee of the pharmaceutical company's pension fund.
He later accepted a position as an SME analyst at Pauli Investment Management and then served as a portfolio manager for Swissfirst Bank, later Bank am Bellevue, from 2005 until 2007.
Postes actifs de Daniel Biedermann
| Sociétés | Poste | Début |
|---|---|---|
2trade Group Ltd.
2trade Group Ltd. Investment ManagersFinance 2trade group is an active, value-based manager which follows a prudent investment style, aiming to provide above-average returns by focusing on investments that are temporarily trading below their fair value. The firm seeks to invest in companies with solid fundamentals, an outstanding management track record and significant potential in their sector. They often employ an anti-cyclical approach. 2trade group meets regularly with company executives and conducts on-site research. | Gestionnaire de Portefeuille-Actions | - |
Anciens postes connus de Daniel Biedermann
| Sociétés | Poste | Fin |
|---|---|---|
Quintet Private Bank (Schweiz) AG
Quintet Private Bank (Schweiz) AG Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Pauli Investment Management AG PIM | Corporate Officer/Principal | - |
Bellevue Asset Management AG
Bellevue Asset Management AG Investment ManagersFinance Bellevue AM is an active, fundamental research-based manager which utilizes a bottom-up investment and anti-cyclical approach that aims to generate above-average returns while keeping risk under control and well monitored. They screen and invest in promising family and owner-managed companies based in Switzerland or the broader European continent through our family of Entrepreneur funds. The firm has become very adept at identifying high growth potential in new and emerging markets, particularly on the African continent. | Gestionnaire de Portefeuille-Actions | 01/01/2007 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bellevue Asset Management AG
Bellevue Asset Management AG Investment ManagersFinance Bellevue AM is an active, fundamental research-based manager which utilizes a bottom-up investment and anti-cyclical approach that aims to generate above-average returns while keeping risk under control and well monitored. They screen and invest in promising family and owner-managed companies based in Switzerland or the broader European continent through our family of Entrepreneur funds. The firm has become very adept at identifying high growth potential in new and emerging markets, particularly on the African continent. | Finance |
Quintet Private Bank (Schweiz) AG
Quintet Private Bank (Schweiz) AG Investment Banks/BrokersFinance Provides brokerage services | Finance |
2trade Group Ltd.
2trade Group Ltd. Investment ManagersFinance 2trade group is an active, value-based manager which follows a prudent investment style, aiming to provide above-average returns by focusing on investments that are temporarily trading below their fair value. The firm seeks to invest in companies with solid fundamentals, an outstanding management track record and significant potential in their sector. They often employ an anti-cyclical approach. 2trade group meets regularly with company executives and conducts on-site research. | Finance |
Pauli Investment Management AG PIM |
















